DEC 27, 2017 5:47 AM PST

Tools, Probes, and Drug Compounds

WRITTEN BY: Courtney Schaal

As drug discovery and the technology utilized in drug discovery has continued to evolve and expand, the tools available to us have also expanded and are important to understand when considering drug discovery, especially in the context of high throughput screening or end goals of an assay. Some screening efforts may be done with a goal in mind to help figure out the biology underlying a certain system, while others may be more purely for clinical utility. In general there are three classes of molecules we use for medicinal chemistry and high throughput screening of large compound libraries. We have chemical tools which are simply backbone molecules that often have multiple analogs with unknown function, unknown targets, unknown cell permeability and a number of other unknown characteristics. Then there are chemical probes. These are small molecules designed toward a specific proteins or target usually aimed to inhibit its function or activity, and which are used to ask mechanistic and phenotypic questions. Chemical probes are better characterized than tool compounds, as we know much more about how and what they can do. Chemical probes have shown to be very useful as they are complementary to genetic based approaches such as RNA interterence, or nowadays CRISPR, but also because they provide unique advantages as they can reversibly alter the function of a protein in a rapid manner. The third class are drug compounds. Drugs are small molecules that are well characterized and tested, and have been optimized for in vivo use as well. There are benefits to each of these classes.

Drug and probe compounds have distinct difference in both purpose and requirements. Drugs are required to be safe and effective, they may not have a defined mechanism of action, usually accompanied with restrictions due to intellectual property or IP surrounding the drug design which may limit is availability for general research use. Drugs also must be bioavailable to humans, and the bar is set high for their physiochemical and pharmaceutic properties. They have set guidelines that must be met in terms of their molecular weight, lipophilicity, stability, they have defined crystal structures, and are able to be synthesized economically and reasonably. Probes, on the other hand, are more often used to ask specific biological questions, such as how does protein A interact with the ability of protein B in its regulation of protein C. For probe compounds, mechanism of action must be defined (unlike drugs), they must be selective toward their intended target, and they are freely available both for use and the data generated from their study. Probes are not required to have some drug-like properties such as bioavailability, and typically they have the added benefit of having a structurally related compound that is inactive towards the intended target that can serve as a negative control in studies using these molecules.

These three classes lay the foundation of medicinal chemistry and small molecules used for various aspects and phases of drug discovery. Often once a compound of interest is determined, structure will be optimized multiple times for functional usage. If a chemical probe proves useful toward studying and understanding a target, if it is also able to inhibit that target it a disease-relevant and meaningful way, this probe could be optimized toward being cell permeable, bioavailable, and be moved toward a drug. These afford us the opportunity to study the biology of disease, interacting properties of molecules, and drug efficacy in our indicated systems.

Sources: Nature Chemical Biology, Wikipedia, Pixabay, Youtube

About the Author
You May Also Like
MAY 18, 2021
Immunology
A Silver Bullet Against COVID Variants?
MAY 18, 2021
A Silver Bullet Against COVID Variants?
Canadian researchers have discovered an antiviral drug that blocks the SARS-CoV-2 virus from infecting lung cells. Promi ...
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
JUN 03, 2021
Drug Discovery & Development
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
JUN 03, 2021
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
  Researchers at the University of Nottingham in the UK and Joint Academy have found that a clinical evidence-based ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUL 12, 2021
Drug Discovery & Development
Testosterone Supplements Reduce Heart Attack and Stroke Risk
JUL 12, 2021
Testosterone Supplements Reduce Heart Attack and Stroke Risk
Taking testosterone supplements significantly reduces risk of heart attack and stroke among men with low levels of the h ...
Loading Comments...